Filing Details

Accession Number:
0001209191-21-053374
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-25 19:32:07
Reporting Period:
2021-08-24
Accepted Time:
2021-08-25 19:32:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1812025 Justin Burgess C/O Dynavax Technologies
2100 Powell Street, Suite 900
Emeryville CA 94608
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-13 2,500 $3.39 9,489 No 4 A Direct
Common Stock Disposition 2021-08-24 5,768 $15.00 3,721 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 13, 2021.
  2. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2021.
  3. All shares were sold at $15.00.